These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19902521)

  • 1. The role of interferons in the treatment of osteosarcoma.
    Whelan J; Patterson D; Perisoglou M; Bielack S; Marina N; Smeland S; Bernstein M
    Pediatr Blood Cancer; 2010 Mar; 54(3):350-4. PubMed ID: 19902521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intact interferon signaling in peripheral blood leukocytes of high-grade osteosarcoma patients.
    Buddingh EP; Ruslan SE; Berghuis D; Gelderblom H; Anninga JK; Hogendoorn PC; Egeler RM; Schilham MW; Lankester AC
    Cancer Immunol Immunother; 2012 Jun; 61(6):941-7. PubMed ID: 22402907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-alpha as the only adjuvant treatment in high-grade osteosarcoma: long term results of the Karolinska Hospital series.
    Müller CR; Smeland S; Bauer HC; Saeter G; Strander H
    Acta Oncol; 2005; 44(5):475-80. PubMed ID: 16118081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant interferon treatment of human osteosarcoma.
    Strander H; Adamson U; Aparisi T; Broström LA; Cantell K; Einhorn S; Hall K; Ingimarsson S; Nilsonne U; Söderberg G
    Recent Results Cancer Res; 1978; 68():40-4. PubMed ID: 288109
    [No Abstract]   [Full Text] [Related]  

  • 5. Interferons and osteosarcoma.
    Strander H
    Cytokine Growth Factor Rev; 2007; 18(5-6):373-80. PubMed ID: 17683971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interferon/Controlled study in 3-year survival of patients with osteosarcoma (author's transl)].
    Kotz R; Plattner E; Ramach W; Flener R; Bodo G
    Arzneimittelforschung; 1982; 32(4):446-8. PubMed ID: 6179524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune reactions and long-term therapy with human leukocyte interferon.
    Ingimarsson S; Cantell K; Carlström G; Dalton B; Paucker K; Strander H
    Acta Med Scand; 1981; 209(1-2):17-19. PubMed ID: 6163328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term adjuvant interferon treatment of human osteosarcoma. A pilot study.
    Strander H; Bauer HC; Brosjö O; Fernberg JO; Kreicbergs A; Nilsonne U; Silfverswärd C; Signomklao T; Söderlund V
    Acta Oncol; 1995; 34(6):877-80. PubMed ID: 7576758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-α/β receptor as a prognostic marker in osteosarcoma.
    Kubo T; Shimose S; Matsuo T; Fujimori J; Arihiro K; Ochi M
    J Bone Joint Surg Am; 2011 Mar; 93(6):519-26. PubMed ID: 21411701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interferons.
    S Afr Med J; 1980 Mar; 57(13):473-4. PubMed ID: 6154319
    [No Abstract]   [Full Text] [Related]  

  • 11. Can historical controls be used in current clinical trials in osteosarcoma. Analysis of Prognostic factors.
    Broström LA; Aparisi T; Ingimarsson S; Lagergren C; Nilsonne U; Strander H; Söderberg G
    Int J Radiat Oncol Biol Phys; 1980 Dec; 6(12):1711-5. PubMed ID: 6165708
    [No Abstract]   [Full Text] [Related]  

  • 12. Interferons: rationale for clinical trials in neoplastic disease.
    Borden EC
    Ann Intern Med; 1979 Sep; 91(3):472-9. PubMed ID: 382941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon and spontaneous cytotoxicity in man. II. Studies in patients receiving exogenous leukocyte interferon.
    Einhorn S; Blomgren H; Strander H
    Acta Med Scand; 1978; 204(6):477-83. PubMed ID: 282781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of osteosarcoma by interferon and differentiated surgery.
    Nilsonne U
    Sem Hop; 1982 Sep; 58(30-31):1764-6. PubMed ID: 6182617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity.
    Link MP; Goorin AM; Miser AW; Green AA; Pratt CB; Belasco JB; Pritchard J; Malpas JS; Baker AR; Kirkpatrick JA
    N Engl J Med; 1986 Jun; 314(25):1600-6. PubMed ID: 3520317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to heat shock protein 90 in osteosarcoma patients correlate with response to neoadjuvant chemotherapy.
    Trieb K; Gerth R; Holzer G; Grohs JG; Berger P; Kotz R
    Br J Cancer; 2000 Jan; 82(1):85-7. PubMed ID: 10638971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moyamoya in a child treated with interferon for recurrent osteosarcoma.
    Buchbinder D; Steinberg G; Linetsky M; Casillas J
    J Pediatr Hematol Oncol; 2010 Aug; 32(6):476-8. PubMed ID: 20562650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interferons.
    Itri LM
    Cancer; 1992 Aug; 70(4 Suppl):940-5. PubMed ID: 1379116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of tumour metastasis in a murine osteosarcoma model with anti-CD25 monoclonal antibody treatment.
    Kozawa E; Sugiura H; Wasa J; Kohyama K; Yamada K; Nishioka A; Nishida Y; Ishiguro N; Taguchi O
    Anticancer Res; 2010 Dec; 30(12):5019-22. PubMed ID: 21187484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenicity of 90Sr induced tumours.
    Nilsson A; Révész L
    Acta Pathol Microbiol Scand A; 1978 Jul; 86(4):331-2. PubMed ID: 281111
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.